May 13 (Reuters) - Johnson & Johnson ( JNJ ) will sell
all its 182.3 million shares in its spun-off company Kenvue ( KVUE )
in a stock offering in a debt-for-equity exchange, the
consumer health product firm said in a filing on Monday.